Medikit Co (TSE:7749) EBITDA Margin %: 7.69% (As of Dec. 2025) — 72% Below Median


TSE:7749 Medikit Co Ltd TSE:7749
80 GF Score
Price 円2,805.00
GF Value 円3,281.26
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Medikit Co EBITDA Margin %?

Medikit Co TSE:7749 -0.18% 80 EBITDA Margin % is 7.69% as of Dec. 2025, which is 72% below its 10-year median of 27.82. GuruFocus rates TSE:7749 with a GF Score™ of 80/100 and a GF Value™ of 円3,281.26 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Medikit Co ranks better than 73.65% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Medikit Co's EBITDA for the three months ended in Dec. 2025 was 円503 Mil. Medikit Co's Revenue for the three months ended in Dec. 2025 was 円6,544 Mil. Therefore, Medikit Co's EBITDA margin for the quarter that ended in Dec. 2025 was 7.69%.


Medikit Co  (TSE:7749) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Medikit Co EBITDA Margin % Related Terms


Medikit Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Medikit Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medikit Co EBITDA Margin % Chart

Medikit Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.56 26.02 28.96 28.19 19.01

Medikit Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.81 18.62 36.98 7.69 12.97

TSE:7749 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison

For the Medical Instruments & Supplies subindustry, Medikit Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medikit Co EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medikit Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Medikit Co's EBITDA Margin % falls into.


TSE:7749
80GF Score
Medikit Co Ltd TSE:7749
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medikit Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Medikit Co's EBITDA Margin % for the fiscal year that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=6356.91/22553.238
=28.19 %

Medikit Co's EBITDA Margin % for the quarter that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=503.339/6544.096
=7.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 7.69% mean?
Medikit Co (TSE:7749) has a EBITDA Margin % of 7.69% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medikit Co and its competitors. This is 72% below median its historical median of 27.82. Over the past decade, Medikit Co's EBITDA Margin % has ranged from 19.01 to 28.96. According to the industry distribution chart, Medikit Co ranks #215 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 26.3%.
Is Medikit Co's EBITDA Margin % too high?
Medikit Co's current EBITDA Margin % of 7.69% is 72% below median its 10-year median of 27.82. Over the past 10 years, this metric has ranged from a low of 19.01 to a high of 28.96. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Medikit Co's value of 7.69% is 2.9% above this industry median. Based on the distribution chart, Medikit Co ranks #215 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medikit Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medikit Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medikit Co ranks #215 out of 816 companies for EBITDA Margin %. This puts Medikit Co in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Medikit Co's value of 7.69% is 2.9% above this benchmark. Historically, Medikit Co's own EBITDA Margin % has ranged from 19.01 to 28.96 over the past decade. While the company's 10-year median is 27.82 vs. the industry median of 7.48, Medikit Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medikit Co's current EBITDA Margin % of 7.69% is 2.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medikit Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medikit Co's current EBITDA Margin % is 7.69%, which is 72% below median its own 10-year median of 27.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medikit Co stock overvalued right now?
Based on GuruFocus' analysis, Medikit Co (TSE:7749) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,281.26, compared to a current price of 円2,805.00 — trading 14.5% below its estimated fair value. The current EBITDA Margin % is 7.69%, which is 72% below median its 10-year median of 27.82 and 2.9% above the Medical Devices & Instruments industry median of 7.48. Medikit Co's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medikit Co (TSE:7749), the current EBITDA Margin % is 7.69% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medikit Co (TSE:7749) Overvalued in 2026?

Based on GuruFocus' analysis, Medikit Co stock appears to be undervalued. The current stock price of 円2,805.00 is trading 14.5% below its estimated GF Value™ of 円3,281.26. GuruFocus considers Medikit Co to be Modestly Undervalued.

Key valuation signals for TSE:7749:

  • EBITDA Margin %: 7.69% (72% below median its 10-year median of 27.82)
  • GF Value™: 円3,281.26 vs. price of 円2,805.00 (14.5% below fair value)
  • GF Score™: 80/100 with 2 warning signs
  • Industry Position: 2.9% above the Medical Devices & Instruments median (#215 of 816)

No single metric tells the full story. See the TSE:7749 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medikit Co Business Description

Address 1-13-2 ,Yushima, Bunkyo-Ku, Tokyo, JPN, 113 0034
Medikit Co Ltd develops, manufactures and sells medical equipment. The company's products offerings are IV Catheter, Hemodialysis, Inner needle, Blood control cap, among others.
80GF Score

Get the complete analysis for TSE:7749

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,805.00
Price
円3,281.26
GF Value